There are 15,355 results relating to "Medicin Viagra-m"
Order by
|
Last updated:
8 September 2023
SPCB Minute 29 June 2023
M inute of the Scottish Parliamentary Corporate Body (SPCB) meeting held on Thursday 29 June 2023 at 9.00am Present: • Alison Johnstone MSP (chair) • Claire Baker MSP • Jackson Carlaw MSP • Maggie Chapman MSP • Christine Grahame MSP In attendance: • David McGill • Michelle Hegarty • Becky Thomson • Helen Birrell • Tracey White • Bill Ward • Alan Durward • ...
Last updated:
8 September 2023
SPCB Minute 29 June 2023
M inute of the Scottish Parliamentary Corporate Body (SPCB) meeting held on Thursday 29 June 2023 at 9.00am Present: • Alison Johnstone MSP (chair) • Claire Baker MSP • Jackson Carlaw MSP • Maggie Chapman MSP • Christine Grahame MSP In attendance: • David McGill • Michelle Hegarty • Becky Thomson • Helen Birrell • Tracey White • Bill Ward • Alan Durward • ...
Last updated:
24 February 2023
SPCB 2023 Paper 02
M embers’ Feedback Interviews 19 January 2023 Reference: SPCB (2023) Paper 02 Executive summary 1.
Last updated:
3 February 2023
SPCB Minute 19 January 2023
The SPCB agreed the minute of the meeting held on 8 December 2022. 1 M atters arising 2. Jackson Carlaw provided feedback following his presentation to the Finance and Public Administration Committee of the SPCB’s 2023-24 Budget. 3.
Last updated:
20 January 2023
SPCB Minute 8 December 2022
M inute of the Scottish Parliamentary Corporate Body (SPCB) meeting held on Thursday 8 December 2022 at 9.00am Present: • Claire Baker MSP (chair) • Jackson Carlaw MSP • Maggie Chapman MSP • Christine Grahame MSP Apologies: • Alison Johnstone MSP In attendance: • David McGill • Michelle Hegarty • Sara Glass • Mairi Pearson • Veronique Malcolm • Huw William...
Last updated:
30 November 2021
Minutes for the Cross-Party Group on WASPI meeting of 26 October 2021
Apologies MSP’s,- Jamie Greene, P Harvie, S Gullane, P Mc Neill, C Haughey, J Hepburn, T Arthur, G Adam, G McKay, M Matheson WASPI – M Grierson, H Smith (Age Scotland) 1- Welcome Intro & Apologies.- Katy introduced herself as the new chair of the group & asked for all attendees to introduce themselves with a little b...
Last updated:
2 April 2026
Hughes Report correspondence from the Minister for Public Health and Womens Health
Public Health Scotland has established a National Medicines in Pregnancy ‘surveillance asset’ focussed on anti-seizure medicines, including valproate, that are known or suspected to have potential to increase the risk of birth defects and development disorders when taken during pregnancy.
Last updated:
16 February 2022
Minutes of the CPG on Epilepsy meeting of 25 November 2021
We are looking at how it may contribute to the work on UK wide medicines registries led by the MHRA. The purpose of these medicines registries is for safety and risk minimisation.
Questions and Answers
Date answered:
9 December 2022
S6W-12558
UNITARY CHARGE PAYMENT CATEGORY 2013-14 2014-15 2015-16 2016-17 2017-18 2018-19 2019-20 2020-21 2021-22 2022-23 TOTAL £m £m £m £m £m £m £m £m £m £m £m PFI/PPP 223 228 230 232 228 234 240 246 252 258 2,370 NPD/HUB 1 3 6 15 35 53 76 85 87 87 448 The NPD model unlike PFI ensures the following:Private sector returns are cappedThere is no dividend bearing equityEnhances stakeholder involvement in the management of projectsSurpluses can be directed in favour of the public sector S6W-12558
Committee reports
Date published:
30 June 2020
Supply and demand for medicines - B. International pricing markets
International pricing markets
We were interested in how the UK's decision to leave the European Union would impact on pricing in the UK and Scotland of medicines.
Warwick Smith, Director General, British Generic Manufacturers Association (BGMA) was supportive of the regulatory landscape in the UK, which he said allowed the market to thrive, emphasising the importance of market forces in maintaining attractive prices when compared with more interventionist regimes in the rest of Europe.iHealth and Sport Committee, Official Report, 21 January 2020, Col 22
While Elizabeth Woodeson, Director of Medicines and Pharmacy, Department of Health and Social Care, saidiHealth and Sport Committee, Official Report, 21 January 2020, Col 19 the UK Government had been clear the price of medicines would not be an issue for discussion in future trade negotiations, there was concerniHealth and Sport Committee, Official Report, 21 January 2020, Col 35 about potential regulatory or licensing provisions which could be part of trade negotiations with the United States of America.
